The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Max with another great prediction. It appears peptides may indeed be the biggest consumer category of 2026. Great for $HIMS, Superpower, and many others. What will be the most popular peptides? Who Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center Peptide Research Overview Mechanisms, Applications & Insights Dr Jonas Programs FDA Peptide Reclassification 2026 Amanecia Health